raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:399096

Distal anoctaminopathy

Synonyms: MMD3 · Miyoshi muscular dystrophy type 3

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Adult
Status
active

Distal anoctaminopathy is a rare, autosomal recessive distal myopathy characterized by early adult-onset, slowly progressive, often asymmetrical, lower limb muscle weakness initially affecting the calves (with relative anterior muscle sparing) and later proximal muscle involvement, as well as highly elevated creatine kinase (CK) serum levels.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDistal anoctaminopathyMMD3 · Miyoshi muscular dystrophy type 3
frAnoctaminopathie distaleDystrophie musculaire de Miyoshi type 3 · MMD3
deAnoctaminopathie, distaleMMD3 · Miyoshi-Muskeldystrophie Typ 3
esAnoctaminopatía distalDistrofia muscular de Miyoshi tipo 3 · MMD3
itAnoctaminopatia distaleDistrofia muscolare di Miyoshi, tipo 3 · MMD3
nlDistale anoctaminopathieMMD3 · Miyoshi spierdystrofie type 3
ptAnoctaminopatia distal
plAnoktaminopatia dystalnaDystrofia mięśniowa Miyoshi typu 3 · MMD3
csDistální anoktaminopatieMMD3 · Miyoshiho svalová dystrofie, typ 3
ukДистальна аноктамінопатіяМязова дистрофія Мійоші, тип 3 · MMD3
zh远端肌张力障碍Miyoshi肌营养不良3型
trDistal anoktaminopatiMMD3 · Miyoshi kas distrofisi tip 3

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613319Evalidated
ICD-10G71.0NTBTattributedvalidated
MONDO0013222Evalidated
MeSHC567645Evalidated
UMLSC2750076Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ANO5Disease-causing germline mutation(s) inAssessedHGNC:27337ENSG0000017171460866211p14.3anoctamin 522980764[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families24 casesWorldwideCase(s)Validated9673985[PMID]_17132147[PMID]_22402862[PMID]_25864073[PMID]_23663589[PMID]_23606453[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_9673985[PMID]_25864073[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2018-12-05
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0009053Distal lower limb muscle weakness
HP:0003323Progressive muscle weakness
Frequent (79-30%)
HP:0009046Difficulty running
HP:0001288Gait disturbance
HP:0030234Highly elevated creatine kinase
HP:0003552Muscle stiffness
HP:0002515Waddling gait
Occasional (29-5%)
HP:0003707Calf muscle pseudohypertrophy
HP:0003693Distal amyotrophy
HP:0009073Progressive proximal muscle weakness
HP:0008997Proximal muscle weakness in upper limbs
Very rare (<4-1%)
HP:0003201Rhabdomyolysis
Excluded (0%)
HP:0009049Peroneal muscle atrophy

Run the differential on the 2 obligate / very frequent terms

Annotation source: 9673985[PMID]

7

Sources for this card